Law firm Araoz y Rueda has been independently engaged by several international and Spanish institutions (the "Clients") holding in aggregate 5.65% of A shares and 3.88% of B shares (including ADRs) in ...
JPMorgan lowered the firm’s price target on Grifols (GRFS) to EUR 9.50 from EUR 14 and keeps a Neutral rating on the shares. Don't Miss our Black Friday Offers: Published first on TheFly – the ...
Mason Capital Management LLC’s Kenneth M Garschina said he wants Grifols SA’s board replaced.Most Read from BloombergRiyadh ...
Grifols negotiates refinancing of bonds maturing next year and €1.4 billion credit line with banks
Link Securities | Grifols (GRF) is in negotiations with banks to refinance bonds maturing next year and a credit line, for a ...
Grifols rejects Brookfield’s €10.5/share offer, signaling undervaluation. Read why GRFS stock is a strong "Buy" despite the ...
Grifols (NASDAQ:GRFS) has commenced discussions with banks to refinance its bonds due in 2025, Bloomberg News reported, a day ...
The accusations are the latest antitrust headache for the tech giant. The decision ends three of the EU competition regulator's attempts to crack down on international companies' tax deals.
Sky News has learnt that Barclays and Brookfield, the Canadian asset management giant, are in detailed talks about a deal that would involve the British lender retaining a 20% stake in the division.
The Spanish pharmaceutical company said it considered Brookfield’s offer of 10.50 euros a share undervalued the company and ...
Expect thin trading on U.S. Thanksgiving holiday: The Toronto Stock Exchange will be front and centre today, as the ...
The board of Spanish plasma-based medicines producer Grifols has announced the termination of discussions with Brookfield ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback